Copyright
©The Author(s) 2004.
World J Gastroenterol. Dec 15, 2004; 10(24): 3650-3653
Published online Dec 15, 2004. doi: 10.3748/wjg.v10.i24.3650
Published online Dec 15, 2004. doi: 10.3748/wjg.v10.i24.3650
n | sFas-medium ng/mL | patients with sFasL (%) | sFasL-medium ng/mL | |
Healthy | 12 | 18.4 | 0 | 0 |
Total healthy HBsAg carriers | 34 | 15.4 | 56 | 0.9 |
Healthy HBsAg carriers | ||||
HBV-DNA < 104/mL or 0 | 12 | 13.6 | 58 | 0.6 |
Healthy HBsAg carriers | ||||
HBV-DNA > 105/mL | 22 | 16.3 | 55 | 1.0 |
Chronic hepatitis B | 33 | 29 | 32 | 0.18 |
Chronic hepatitis C | 19 | 28 | 68 | 1.0 |
- Citation: Lapinski TW, Kowalczuk O, Prokopowicz D, Chyczewski L. Serum concentration of sFas and sFasL in healthy HBsAg carriers, chronic viral hepatitis B and C patients. World J Gastroenterol 2004; 10(24): 3650-3653
- URL: https://www.wjgnet.com/1007-9327/full/v10/i24/3650.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i24.3650